1. Home
  2. IPSC vs SBFG Comparison

IPSC vs SBFG Comparison

Compare IPSC & SBFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • SBFG
  • Stock Information
  • Founded
  • IPSC 2019
  • SBFG 1983
  • Country
  • IPSC United States
  • SBFG United States
  • Employees
  • IPSC N/A
  • SBFG 251
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • SBFG Major Banks
  • Sector
  • IPSC Health Care
  • SBFG Finance
  • Exchange
  • IPSC Nasdaq
  • SBFG Nasdaq
  • Market Cap
  • IPSC 146.2M
  • SBFG 139.1M
  • IPO Year
  • IPSC 2021
  • SBFG N/A
  • Fundamental
  • Price
  • IPSC $1.10
  • SBFG $20.91
  • Analyst Decision
  • IPSC Strong Buy
  • SBFG
  • Analyst Count
  • IPSC 4
  • SBFG 0
  • Target Price
  • IPSC $13.00
  • SBFG N/A
  • AVG Volume (30 Days)
  • IPSC 864.2K
  • SBFG 37.7K
  • Earning Date
  • IPSC 11-05-2024
  • SBFG 01-23-2025
  • Dividend Yield
  • IPSC N/A
  • SBFG 2.77%
  • EPS Growth
  • IPSC N/A
  • SBFG 3.68
  • EPS
  • IPSC N/A
  • SBFG 1.74
  • Revenue
  • IPSC $2,684,000.00
  • SBFG $56,732,000.00
  • Revenue This Year
  • IPSC $230.56
  • SBFG N/A
  • Revenue Next Year
  • IPSC $31.85
  • SBFG $4.16
  • P/E Ratio
  • IPSC N/A
  • SBFG $11.99
  • Revenue Growth
  • IPSC 7.88
  • SBFG 1.21
  • 52 Week Low
  • IPSC $0.98
  • SBFG $13.01
  • 52 Week High
  • IPSC $5.51
  • SBFG $23.00
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 36.74
  • SBFG 45.57
  • Support Level
  • IPSC $0.98
  • SBFG $20.98
  • Resistance Level
  • IPSC $1.74
  • SBFG $23.00
  • Average True Range (ATR)
  • IPSC 0.14
  • SBFG 0.65
  • MACD
  • IPSC -0.04
  • SBFG -0.08
  • Stochastic Oscillator
  • IPSC 15.79
  • SBFG 0.00

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

About SBFG SB Financial Group Inc.

SB Financial Group Inc operates as a Holding Company of State Bank and RDSI/DCM. Its activities involve commercial banking, trust, and financial services. It offers a full-range of financial services for consumers and small businesses, including trust services, mortgage banking, wealth management services, commercial and agricultural lending. It accepts deposits, such as checking accounts, savings accounts, money market accounts, demand deposits, and time certificates of deposit. It earns revenue in the form of interest income.

Share on Social Networks: